SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,823.54 -118.08
(-0.23%)

Dow Jones

7,358.68 -19.81
(-0.27%)

Hang Seng

69,065.93 -3,300.41
(-4.56%)

Nikkei 225

10,515.14 -14.75
(-0.14%)

Forex

USD-INR

94.41 -0.14
(-0.15%)

EUR-INR

107.28 -0.07
(-0.07%)

GBP-INR

124.48 -0.08
(-0.06%)

JPY-INR

0.58 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

48.09

EPS(TTM)

Face Value()

Div & Yield %

Back

SBC Exports consolidated net profit rises 206.01% in the December 2025 quarter

Feb 06,2026

Net profit of SBC Exports rose 206.01% to Rs 11.20 crore in the quarter ended December 2025 as against Rs 3.66 crore during the previous quarter ended December 2024. Sales rose 44.99% to Rs 104.45 crore in the quarter ended December 2025 as against Rs 72.04 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	104.45	72.04	45
OPM %	11.31	2.55	-
PBDT	11.69	4.09	186
PBT	11.20	3.66	206
NP	11.20	3.66	206

77,100.47 109.25 ( 0.14%)

51,823.54 -118.08 (-0.23%)

7,358.68 -19.81 (-0.27%)

69,065.93 -3,300.41 (-4.56%)

10,515.14 -14.75 (-0.14%)

94.41 -0.14 (-0.15%)

107.28 -0.07 (-0.07%)

124.48 -0.08 (-0.06%)

0.58 0.00 (-0.20%)